Overview

Civamide in OA of the Knee(s)

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis (OA) of the Knee(s).
Phase:
Phase 3
Details
Lead Sponsor:
Winston Laboratories
Treatments:
Capsaicin